Endovascular Aneurysm Repair Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Endovascular Aneurysm Repair |
Due to its benefits over open surgery, Endovascular Aneurysm Repair (EVAR) is a favoured method of
treating aortic aneurysm. These benefits include absence of abdominal surgery,
quicker recovery times, and better patient outcomes. The EVAR operation is
hence known as the "standard intervention" for abdominal aortic aneurysm
(AAA). In this operation, a stent is inserted into the aorta's aneurysmal area
to create a permanent alternate blood flow pathway within the patient's
vasculature and stop the aneurysmal sac from being under blood flow pressure
and rupturing.
Even though EVAR considerably reduces operating room dangers
and recovery time when compared to open surgery, Endovascular
Aneurysm Repair Market still
has room for development. This is explained by the endoleak incidents that have
occurred after EVAR procedures. However, market participants have created
cutting-edge technologies of the next generation in order to overcome such
difficulties. For instance, Endologix Inc., the first and only endovascular
sealing solution helpful in preventing all forms of endoleaks, has
game-changing new generation Nellix technology and got FDA approval for its
percutaneous endograft delivery system.
In 2021, the Endovascular
Aneurysm Repair Market in North America still held a decisive 33% of the
global market. It is brought on by the high prevalence of aneurysms and the
conditions that encourage their development. Additionally, the area focuses on
developing and innovating dependable medical infrastructure products, which
further helps the market's growth. About 116 million adults in the USA, or
about half of all adults, have hypertension, which is a primary contributor of
aneurysms. The Centers for Disease Control and Prevention estimate that there
are 17,220 aneurysms recorded per year in North America.
A 2016 study in the New England Journal of Medicine found a
significant rise in patients choosing endovascular aneurysm repair between 2005
and 2012. For instance, in 2005, almost 50% of aneurysm patients in the U.S.
chose EVAR; by 2012, that number had climbed to 75.4%. In England, a similar
pattern was seen. Customers' growing interest in this ground-breaking surgery
is attributable to the fact that it uses a minimally invasive treatment
approach that promotes quick healing, requires little hospital time, and leaves
fewer scars. This is anticipated to support market expansion.
Product Type
·
Fenestrated
Stent Graft
·
Adjunctive
Stent Graft
·
Branched
Stent Graft
·
Others
By Indication
·
Abdominal
Aortic Aneurysm (AAA)
·
Thoracic
Aortic aneurysm (TAA)
·
Descending
Aortic Aneurysm
·
Ascending
Aortic Aneurysm
By End Users
·
Hospitals
·
Ambulatory
care services
·
Specialty
clinics
Major Companies are Medtronic plc. Cook Medical, Gore
Medical, B. Braun Melsungen AG, Terumo Corporation, Boston Scientific
Corporation, Abbott Laboratories, Volcano Corporation, C.R. Bard, Spectranetics
International BV, Cordis Corporation (Johnson and Johnson Co.), and St. Jude
Medical Inc.
Comments
Post a Comment